Cargando…
Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
Since the discovery of RNA splicing more than 40 years ago, our comprehension of the molecular events orchestrating constitutive and alternative splicing has greatly improved. Dysregulation of pre‐mRNA splicing has been observed in many human diseases including neurodegenerative diseases and cancer....
Autores principales: | Taylor, Justin, Lee, Stanley C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852509/ https://www.ncbi.nlm.nih.gov/pubmed/31334570 http://dx.doi.org/10.1002/gcc.22784 |
Ejemplares similares
-
Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
por: Ochi, Yotaro, et al.
Publicado: (2021) -
Modulation of splicing catalysis for therapeutic targeting of leukemias with spliceosomal mutations
por: Lee, Stanley Chun-Wei, et al.
Publicado: (2016) -
Spliceosome Mutations in Uveal Melanoma
por: Nguyen, Josephine Q.N., et al.
Publicado: (2020) -
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
por: Lebecque, Benjamin, et al.
Publicado: (2022) -
Mutations in spliceosomal proteins and retina degeneration
por: Růžičková, Šárka, et al.
Publicado: (2016)